selenious acid has been researched along with Amyotrophic Lateral Sclerosis in 1 studies
Selenious Acid: A selenium compound with the molecular formula H2SO3. It used as a source of SELENIUM, especially for patients that develop selenium deficiency following prolonged PARENTERAL NUTRITION.
Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vinceti, M | 1 |
Solovyev, N | 1 |
Mandrioli, J | 1 |
Crespi, CM | 1 |
Bonvicini, F | 1 |
Arcolin, E | 1 |
Georgoulopoulou, E | 1 |
Michalke, B | 1 |
1 other study available for selenious acid and Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite.
Topics: Adult; Age Factors; Aged; Amyotrophic Lateral Sclerosis; Case-Control Studies; Female; Humans; Male; | 2013 |